Introduction
Notch signaling participates in neoplastic transformation in various cell types (Nickoloff et al., 2003; Miele, 2006; Miele et al., 2006) . The role of Notch signaling in cervical cancer has been intensely studied, but remains controversial. Increased expression of Notch-1 in advanced cervical intraepithelial neoplastic lesions and cervical carcinomas was described in 1995 (Zagouras et al., 1995) and subsequently confirmed (Daniel et al., 1997) . Notch ligands Delta-1 and Jagged-1 were also reported to be increased in cervical carcinomas (Gray et al., 1999) . HPV16 oncoproteins E6 and E7 increase Notch-1 levels and C-promoter binding factor-1 (CBF-1) transcriptional activity in primary mouse embryo cells (Weijzen et al., 2003) . Enforced expression of Notch-1 N IC was reported to cooperate with human papilloma virus (HPV) oncoproteins in transforming immortalized human keratinocytes, through the AKT pathway (Rangarajan et al., 2001) . Antisense silencing of Notch-1 in CaSki cervical cancer cells abolishes proliferation and anchorage-independent growth in vitro (Weijzen et al., 2002) and abolishes the growth of CaSki xenografts in vivo (Weijzen et al., 2003) . In apparent contrast with these observations, Talora et al. (2002) showed that enforced expression of constitutively active Notch-1 slows the growth of cervical cancer cells in vitro and inhibits expression of E6 and E7, suggesting that specific downmodulation of Notch-1 may be required to sustain the transforming activity of HPV oncoproteins. Subsequently, Lathion et al. (2003) showed that the effects of Notch-1 in cervical keratinocytes are strikingly dose-dependent: high levels of constitutively active Notch-1 suppress E6 and E7 as found by Talora et al. (2002) , but moderate levels of Notch-1 promote keratinocyte transformation by E6 and E7.
Immunohistochemistry data of 352 patients (Ramdass et al., 2006) indicate that activation of Notch signaling, as determined by expression levels of intracellular Notch-1, HES1, CDK9 and Jagged-1, is observed in the majority of cervical cancer, and is accompanied by activation of the nuclear factor-kappa B (NF-kB) pathway, as determined by nuclear staining for p50 and p65 and expression of NF-kB target genes. Constitutive activation of NF-kB with nuclear accumulation of p50 and p65 with cervical cancer progression has been described (Nair et al., 2003; Prusty et al., 2005) . Inhibition of NF-kB sensitizes cervical cancer cells to cisplatin (Venkatraman et al., 2005) . The cytotoxicity of arsenic trioxide (Woo et al., 2004; Wei et al., 2005) and celecoxib (Kim et al., 2004) on cervical cancer cells is mediated in part by NF-kB inhibition. Notch-1 is known to have complex, context-dependent cross talk with NF-kB, mediated by multiple cytoplasmic and nuclear pathways (Osipo et al., 2008) . Recently, we (Vilimas et al., 2007) showed that overexpression of Notch-1 IC in a mouse model of T-cell acute lymphoblastic leukemia (T-ALL) and in human T-ALL cells activates NF-kB by interacting with the I kappa B kinase (IKK) signalosome and enhancing IkB kinase activity. However, it remained unclear whether this interaction is a feature of T-ALL cells, which overexpress Notch-1 IC and frequently carry Notch-1 mutations, a T-cell-specific phenomenon or a more general feature of wild-type spontaneously expressed Notch-1. On the basis of these observations, we studied the cross talk between Notch-1 and NF-kB in cervical cancer cells.
Results
Notch-1, -2 and -4 are expressed in clinical specimens of cervical cancer and cervical cancer cell lines We examined 25 archival cases (five cervical intraepithelial neoplasia grade 3 and 20 cervical carcinomas from the Mexican Institute for Social Security) by immunohistochemistry ( Figure 1a , top panels). In all these cases, Notch-1, -2 and -4 were clearly expressed, with a mostly diffuse cytoplasmic pattern, whereas Notch-3 was negative. Notch-1 data are consistent with previous observations (Zagouras et al., 1995; Daniel et al., 1997; Ramdass et al., 2006) . In an independent set of 22 samples from University of Southern California, we did not find a statistically significant difference in the number of cases showing strong Notch-1 staining (7/11 normal, 6/11 cancers). The only notable difference was the distribution of Notch-1 staining, which in cancers was more commonly full thickness, diffuse cytoplasmic staining, whereas in normal cervix was more commonly basal/parabasal, membrane-localized and punctate ( Figure 1a , bottom panels). Antibody specificity was validated by transfecting intracellular forms of all four Notch receptors into primary keratinocytes (not shown). Notch-1 signal was consistently observed with goat or rabbit polyclonal antibodies that recognized the C terminus of Notch-1 receptor (Santa Cruz C-20), but appeared to be weak or absent with a rat monoclonal antibody from the (Talora et al., 2002) . We did not observe striking differences in signal intensity between normal and cancer specimens. Given the quantitative limitations of immunohistochemistry and the differences in cellular distribution, we could not determine whether the overall level of Notch-1 was significantly different. However, our data confirm that Notch-1 is commonly expressed in cervical cancer. Consistent with these observations and with published evidence (Lathion et al., 2003) , we observed similar expression profiles in a panel of four HPV-16-positive human cervical cancer cell lines (Figure 1b) . In summary, Notch-1, -2 and -4 were found to be expressed in cervical cancer specimens and cervical cancer cell lines. Notch-3 was undetectable in cervical cancers and was negative in three out of four cell lines.
All cervical cancer lines we tested also express at least one Notch ligand and the catalytic subunit of g-secretase.
Notch-1 maintains NF-kB activity in CaSki cells
To investigate the possible cross talk of Notch-1 with NF-kB, we utilized small interfering RNA (siRNA) knockdown and g-secretase inhibition to modulate Notch signaling (see Supplementary Information and Supplementary Figure 1 for a detailed description of reagent validation). We examined the effects of Notch-1 signaling on NF-kB transcriptional activity by luciferase reporter assays using siRNA or overexpression approaches. Notch-1 silencing by siRNA resulted in approximately 50% decrease in NF-kB-driven luciferase activity with or without tumor necrosis factor (TNF)-a stimulation ( Figure 2a) . Overexpression of Notch-1 N IC led to a dose-dependent increase of NF-kB reporter activity up to 0.2 mg DNA per well in a 24-well-plate format ( Figure 2b ). However, higher levels of Notch-1 expression resulted in lower stimulation, consistent with published observations in Jurkat cells (Guan et al., 1996; Wang et al., 2001) . The inhibition of NF-kB reporter activity by Notch-1 siRNA was abrogated by overexpression of p50 plus p65 in a dose-dependent manner ( Figure 2c ). In agreement with siRNA data, treatment of CaSki cells with g-secretase inhibitor I (GSI) suppressed NF-kB reporter activity in a dose-dependent manner, with IC 50 between 1 and 2 mM (Figure 2d ). This effect was rescued by concomitant transfection of Notch-1 N IC , which does not need to be cleaved by g-secretase. DNA enzyme-linked immunosorbent assay data ( Figure 2e ) showed that Notch-1 siRNA significantly lowered the levels of DNA binding-competent p50, p65 and c-Rel in CaSki nuclear extracts, but had no effect on p52 or RelB. The effect of Notch-1 siRNA on p50 and p65 DNA-binding activities was not due to modulation of their total protein levels ( Figure 2f ). Treatment with GSI caused profound and dose-dependent inhibition of DNA binding by p50, p65 and c-Rel, but not p52 or Rel-B, consistent with the effects of Notch-1 siRNA (Figure 2g ). These data suggest that Notch-1 plays a role in maintaining canonical NF-kB activity in cervical cancer cells without affecting the alternate NF-kB2 pathway. This effect was specific for Notch-1, because knockdown of either Notch-2 or Notch-4 had no effect on NF-kB reporter activity, whereas it did partially inhibit CBF-1 reporter activity (Supplementary Figure 1G and H).
Notch-1 interacts with IKKa and enhances IkB kinase activity Our data showed that activating Notch-1 signaling promotes the DNA-binding activities of p50 and p65 without altering their expression levels in CaSki cells, implying that Notch-1 signaling may activate NF-kB signaling through the classical p50/p65 pathway, which requires IKK-mediated IkB degradation. Therefore, we tested whether Notch-1 might interact with IkB kinases, as recently described in T-ALL cells (Vilimas et al., 2007) . Figure 3a shows that IKKa could be readily immunoprecipitated from total cell extracts with two different Notch-1 antibodies directed against two distinct epitopes. With these two antibodies, which recognize all forms of Notch-1, we consistently failed to immunoprecipitate IKKb or IKKg. This may indicate either that Notch-1 in these cells associates with IKKa alone, as does Notch-3 (Vacca et al., 2006) , or that Notch-1/IKKa complexes are more abundant than Notch-1/IKK signalosome complexes under basal conditions and are easier to detect. Indeed, when we immunoprecipitated CaSki extracts with an antibody to the cleaved form of Notch-1, N IC , a small fraction of total Notch-1, we were able to detect IKKb and IKKg (Figure 3b ). 'Reverse' immunoprecipitation with IKKa antibodies detected Notch-1 in CaSki total cell extracts ( Figure 3c ). Interestingly, reverse immunoprecipitation also detected complexes containing Notch-1 and IKKa in nuclear extracts (Figure 3c ), suggesting a possible role of Notch-1 in modulating the nuclear functions of IKKa. The identity of the Notch-1 form interacting with IKKa was confirmed by immunoprecipitating total cell and nuclear extracts with IKKa antibodies and detecting Notch-1 with another Notch-1 N IC -specific antibody (Cell Signaling, Danvers, MA, USA) that does not recognize uncleaved Notch-1. An N IC band migrating at approximately 98 kDa was immunoprecipitated by IKKa antibodies in both total and nuclear extracts. The same band was also immunoprecipitated by Notch-1 C-terminal antibodies (Santa Cruz). The theoretical mass of Notch-1 N IC is 96 kDa. Both direct and reverse immunoprecipitation experiments detected a Notch-1/IKKa-containing complex in normal keratinocytes as well (Figure 3e ), indicating that this complex is not exclusive to CaSki and T-ALL cell lines. To confirm the interaction, we used a quantitative immunoprecipitation assay described by Vooijs et al. (2004) . This assay uses a full-length Notch-1 construct tagged at the C terminus with Renilla luciferase. By measuring luciferase activity specifically immunoprecipitated with antibodies to , and their corresponding empty vectors, respectively. The effects of Notch signaling modulation on NF-kB transcriptional activity were assessed by monitoring NF-kB promoter-driven luciferase activity after 48 h. Relative luciferase activity was calculated considering 1.0 as the activity of cells transfected with empty vector. *Pp0.005. Western blots (right) show Notch-1 expression levels for the same experiments. (c) Cells in 24-well-plate format were transfected with NF-kB-luciferase reporter plasmid plus pTK-luciferase plasmid as internal controls, as well as empty vector or plasmids encoding Notch-1 siRNA plus empty vector or the indicated amounts of p50-and p65-encoding plasmids in equimolar amounts. Total DNA used for transfection was kept constant by varying the amounts of empty vector. Forty-eight hours post-transfection, dual-luciferase assays were performed. (Figures 3f and g ). We did not observe quantitative differences between vehicle-and TNF-a-treated cells. However, although in vehicle-treated cells, IKKb antibodies consistently gave signals that were not significantly higher than control, in TNF-a-treated cells, this assay consistently detected a specific interaction also with IKKb antibodies (Figure 3g ). This may suggest that TNF-a affects the composition or stability of the IKK/Notch-1-containing complexes.
To probe the functional significance of this interaction, we explored endogenous IkBa phosphorylation by western blotting. Figure 3h shows that siRNA-mediated knockdown of Notch-1 for 48 h reduced the basal levels of endogenous IkBa. Phospho-IkBa was very low under basal conditions and was also decreased, most likely as a consequence of lower total protein levels. However, after 1 h TNF-a stimulation, the phosphorylation of endogenous IkBa was virtually abolished by Notch-1 siRNA, and total IkBa levels were comparable to control. We interpreted this data to indicate that Notch-1 knockdown for 48 h inhibits basal NF-kB activity by undetermined mechanisms, reducing expression of NF-kB targets including IkBa. After TNF-a stimulation, Notch-1 is required for IKK signalosome activation and IkBa phosphorylation, and Notch-1 knockdown prevents IkBa phosphorylation. Shorter term Notch inhibition was achieved with 18 h GSI treatment. Under these conditions, GSI did not significantly affect total IkBa expression, but like Notch-1 siRNA, it inhibited TNF-a-stimulated IkBa phosphorylation, which at 60 min was abolished (Figure 3i ). We further tested our model by in vitro immunoprecipitation kinase assays using a commercially available glutathione S-transferase-full-length IkBa fusion protein substrate. Figure 3j shows that an IkBa kinase activity could be immunoprecipitated with antibodies to IKKa, IKKb or Notch-1. Notch-1 knockdown did not inhibit basal IKKa-or IKKb-immunoprecipitated kinase activity, but did inhibit basal Notch-1-associated activity. In TNF-a-stimulated cells, Notch-1 knockdown markedly inhibited IkBa kinase activity immunoprecipitated with IKKa, IKKb or Notch-1. TNF-a increased only the kinase activity immunoprecipitated with IKKb antibodies, but not that immunoprecipitated with IKKa and Notch-1 antibodies. This is consistent with the fact that TNF-a does not affect the amount of Notch-1/IKKa complexes, which appear to pre-exist and be relatively abundant under basal conditions, but does increase Notch-1/IKKb interactions (Figures 3f  and g ). Notch-1 knockdown had minimal effects on expression levels of IKKa or IKKb proteins (Figure 3j ) and no significant effects on IKKa or IKKb mRNA (not shown). These results indicate that endogenous Notch-1 modulates NF-kB activity in TNF-a-stimulated CaSki cells at least in part by physically interacting with the IKK signalosome and regulating its IkB kinase activity. This is analogous to the recently demonstrated role of Notch-1 in T-ALL cells and suggests that IKK modulation may be a physiological function of Notch-1 rather than a T-cell-specific effect or a result of the massive Notch-1 overexpression that occurs in T-ALL cells. Under basal conditions, Notch-1 is associated with a fraction of cellular IkBa kinase activity, but this does not appear to regulate background phosphorylation of endogenous IkBa. Thus, the function of the NotchIKKa complex detected under basal conditions remained unclear, as did the mechanism whereby Notch affects basal NF-kB activity.
Notch-1 colocalizes with IKKa at NF-kB-responsive promoters and is required for IKKa chromatin association The presence of Notch-1/IKKa-containing complexes in nuclear extracts prompted us to investigate whether Notch-1 may regulate the nuclear functions of IKKa and through these, NF-kB target gene expression. In recent years, multiple nuclear roles of IKKa in the regulation of NF-kB target gene expression have been described (Perkins, 2007) . IKKa functions as a chromatin-associated kinase that contributes to NF-kBmediated transcription by phosphorylating histone H3 (Anest et al., 2003; Yamamoto et al., 2003) , as well as p65 and corepressor SMRT (silencing mediator of retinoid and thyroid hormone receptors) at NF-kBresponsive elements, de-repressing transcription (Hoberg et al., 2004 (Hoberg et al., , 2006 . To examine whether Notch-1 participates in the nuclear functions of IKKa, we used chromatin immunoprecipitation (ChIP) to analyse the impact of Notch-1 on the chromatin recruitment of IKKa at the IkBa promoter, an NF-kB-dependent promoter regulated by IKKa (Yamamoto et al., 2003) . Semiquantitative ChIP experiments indicated that TNFa-stimulated recruitment of IKKa to this promoter requires Notch-1 (Supplementary Figure 2) . We used real-time ChIP to test this model (Figure 4a ). Under basal conditions, IKKa was present at the IkBa promoter in small but detectable amounts, which appeared decreased by Notch-1 siRNA. After TNF-a stimulation, both Notch-1 and IKKa were prominently recruited to the IkBa promoter, and Notch-1 knockdown abolished recruitment of IKKa to the promoter. We confirmed this observation by studying c-IAP2, another promoter regulated by IKKa in the presence of TNF-a (Anest et al., 2003; Yamamoto et al., 2003) . Real-time ChIP experiments (Figure 4b) showed that under basal conditions, Notch-1 and IKKa are found in association with the c-IAP2 promoter in CaSki cells. In the presence of TNF-a, additional Notch-1 and IKKa are recruited at the promoter. Notch-1 siRNA abolished the presence of either Notch-1 or IKKa at the c-IAP2 promoter under both basal and TNF-a-stimulated conditions. Additional ChIP experiments (not shown) determined that treatment of CaSki cells with GSI led to dose-dependent disappearance of both Notch-1 and IKKa from the c-IAP2 promoter. Consistent with these observations, Notch-1 siRNA abrogated the increase in c-IAP2 mRNA caused by TNF-a (Figure 4c) . These data support a model in which chromatin association of IKKa requires Notch-1, and Notch-1/IKKa complexes participate in transcriptional regulation at NF-kBresponsive promoters under basal conditions and after TNF-a stimulation.
Bidirectional cross talk between Notch and NF-kB IKKa associates with the HES-1 promoter, a quintessential Notch/CBF-1 target, and de-represses it by phosphorylating promoter-associated IkBa (Aguilera et al., 2004) Figure 5 shows that in untreated cells, both IKKa and IKKb knockdown suppressed basal NF-kB reporter activity (Figure 5a ) as well as CBF-1 reporter activity (Figure 5b) . In TNF-a-treated cells, silencing of either IKKa or IKKb markedly inhibited NF-kB and CBF-1 reporter activity (Figures 5c and d) . Specific knockdown was verified by western blotting (Figure 5e ). We interpreted these data as an indication that in CaSki cells, IKKa and IKKb are required for a fraction of basal endogenous NF-kB activity as well as TNF-a-induced activity. In addition, at least in these cells, IKKa and IKKb function as cofactors for canonical Notch-mediated CBF-1 activation. Whether this is due to phosphorylation of nuclear IkBa or SMRT, or due to NF-kB-mediated regulation of Notch ligands (Bash et al., 1999) remains to be determined. However, our data indicate that in these cells, the Notch and NF-kB pathways are closely integrated by bidirectional cross talk mediated by the IKK kinases.
The Notch-1-IKKa pathway antagonizes cisplatin-induced toxicity in CaSki cells Our studies revealed that Notch-1 maintains NF-kB activity in cervical cancer cells at least in part via associating with nuclear IKKa under basal conditions and with nuclear IKKa and the IKK signalosome in the presence of TNF-a. Constitutive activation of NF-kB enhances resistance to chemotherapy and radiation in many malignancies. Thus, we evaluated the effects of Notch-1 and IKKa silencing on cisplatininduced cytotoxicity in CaSki cells. Notch-1 knockdown by siRNA significantly potentiated cisplatin-induced cytotoxicity, lowering the IC 50 value of cisplatin in CaSki cells by almost two orders of magnitude, from 27.3 to 0.46 mM (Figure 6a ). IKKa knockdown also strikingly increased cisplatin-induced cytotoxicity to an extent comparable to that caused by Notch-1 knockdown ( Figure 6b ). Annexin-V flow cytometry ( Figure 6c ) indicated that cytotoxicity was at least in part due to apoptosis. Either Notch-1 or IKKa siRNAs dramatically inhibited both NF-kB and CBF-1 reporter activity in the presence or absence of 10 mM cisplatin (Figures 6d and e) , consistent with the hypothesis that NF-kB and CBF-1 activities are (Vooijs et al., 2004) . Forty-eight hours after transfection, cells were treated for 30 min with vehicle or TNF-a (10 ng/ml). Cells were lysed and reverse immunoprecipitations were carried out with antibodies to IKKa, IKKb or control IgG. Renilla luciferase activity in washed pellets was determined and compared to total Renilla luciferase activity (pellet plus combined supernatants). Data are representative of three independent experiments, each conducted in triplicate. (h) Cells were transiently transfected with either control empty vector or plasmid encoding Notch-1 siRNA. Forty-eight hours post-transfection, cells were stimulated with or without TNF-a (10 ng/ml) for 30 or 60 min and analysed by western blotting for phospho-IkBa and total IkBa. (i) Cells were treated for 18 h with vehicle (DMSO) or 2 mM GSI and then stimulated with or without TNF-a (10 ng/ml) for 30 or 60 min and analysed by western blotting for phospho-IkBa and total IkBa. Note that GSI effect was apparent at 60 min, possibly indicating a shorter duration of IkBa phosphorylation. (j) Cells were transiently transfected with either control empty vector or plasmid encoding Notch-1 siRNA. Forty-eight hours post-transfection, cells were stimulated with or without TNF-a (10 ng/ml) for 30 min. Knockdown was verified by western blotting (top panel). For each condition, 300 mg whole-cell extract was immunoprecipitated with antibodies to IKKa, IKKb or Notch-1 (C-20 Santa Cruz). Kinase activity was determined using glutathione S-transferase-IkBa as a substrate, followed by SDS-polyacrylamide gel electrophoresis and autoradiography. Levels of Notch-1, IKKa and IKKb and b-actin were determined by western blotting in the same cell lysates used for immunoprecipitation (bottom three panels). Note that only with IKKb antibodies did we see induction of kinase activity by TNF-a, consistent with the fact that IKKb is primarily responsible for cytoplasmic phosphorylation of IkBa. This may reflect the fact that IKKa in these cells is present not only in the IKK signalosome, but also as Notch-1-bound homodimers that are not increased or activated by TNF-a but do migrate to the nucleus (Figure 4 ). This may mask the effect of TNF-a when immunoprecipitating for total IKKa. Data shown represent five individual experiments. DMSO, dimethylsulfoxide; IKK, I kappa B kinase; TNF-a, tumor necrosis factor-a.
Notch-1 regulates IKKa LL Song et al closely integrated in these cells and contribute to their survival.
Discussion
A role for Notch signaling in cervical cancer was suggested more than a decade ago (Zagouras et al., 1995) , but has remained controversial. Both overexpression and loss of Notch-1 have been suggested in cervical cancer. It is difficult to compare data obtained with different antibodies by different groups, and immunohistochemistry is hardly quantitative. However, our data indicate that Notch-1 protein is at least present in most cervical carcinomas, in agreement with Ramdass et al. (2006) and in cervical carcinoma lines, in agreement with Lathion et al. (2003) . Notch-2 and -4 are coexpressed with Notch-1. The pattern of Notch-1 expression appears to change from granular, membrane-associated in normal cells to diffuse, primarily cytoplasmic in cancer cells. This may be responsible for apparent differences in published reports. Regardless of the relative levels of Notch-1 compared to normal cells, complete loss of Notch-1 is incompatible with survival in CaSki cervical cancer cells in vitro and in vivo (Weijzen et al., 2002 (Weijzen et al., , 2003 . We now show that endogenously expressed Notch-1 promotes the survival of these cells at least in part through the NF-kB pathway and suggests two novel IKK-mediated mechanisms for NF-kB activation by Notch-1. In the presence of TNF-a, similar to murine and human T-ALL cells overexpressing Notch-1, wild-type Notch-1 in CaSki cells associates with the IKK signalosome, most likely via IKKa, and stimulates cellular IkB kinase activity. In addition, we report for the first time that Notch-1/IKKa-containing complexes are present under basal conditions in CaSki cells. These complexes are detectable in the nucleus, and Notch-1 is required for association of IKKa with promoters known to require its chromatin kinase activity under basal conditions and after TNF-a stimulation. TNF-a does not appear to affect the formation of Notch-1/IKKa complexes but it does increase their chromatin recruitment. It is unclear whether Notch-1 and IKKa migrate to the nucleus as a complex or associate in the nucleus. However, the presence of both cytoplasmic and nuclear complexes containing Notch-1 and IKKa suggests that the two proteins may cotranslocate to the nucleus. Notch-3 binds and activate IKKa homodimers in murine thymocytes (Vacca et al., 2006) . However, in that system, Notch-3 binding results in NIK-independent activation of the cytoplasmic functions of IKKa, leading to the activation of p52/RelB heterodimers. In CaSki cells, the p52/RelB pathway is not affected by modulation of Notch-1 expression or activity. Together with (Vacca et al., 2006; Vilimas et al., 2007) , our data suggest that different Notch homologs modulate IKKa and NF-kB in different ways, namely by activating the alternate NF-kB pathway via cytoplasmic IKKa in the case of Notch-3 and by activating the canonical NF-kB pathway via the IKK signalosome and nuclear IKKa in the case of Notch-1. In CaSki cells, Notch-2 and -4 did not affect NF-kB. In normal murine T cells, Notch-1 activates NF-kB by directly interacting with p50/c-Rel heterodimers and facilitating their nuclear retention (Shin et al., 2006) . In CaSki cells, although we did confirm that Notch-1 N IC can be detected in association with p50, as previously shown (Guan et al., 1996; Wang et al., 2001 ), we could not detect p65 in association with Notch in nuclear or cytoplasmic lysates (not shown). We cannot rule out direct interaction with NF-kB as an additional mechanism for activation or the formation of large chromatin complexes including Notch, IKKa and NF-kB. Our data also indicate that both IKKa and IKKb enhance canonical CBF-1 activity in CaSki cells. This may be due to the mechanisms described by the Bigas group (Fernandez-Majada et al., 2007) and/or due to the upregulation of Notch ligands by NF-kB (Bash et al., 1999) .
Our data and those of Vilimas et al. (2007) suggest that agents that inhibit Notch signaling, such as the g-secretase inhibitors currently in clinical development, may affect the IKK signalosome and IKKa signaling in some cancer cells. In addition, our data suggest that IKK inhibition may be an alternative way of inhibiting Notch signaling without targeting g-secretase, while simultaneously achieving inhibition of NF-kB. The IKK-NF-kB axis is a very attractive therapeutic target in numerous malignancies (Yamamoto and Gaynor, 2001; Lin and Karin, 2003; Karin et al., 2004) . On the basis of our data, drugs that inhibit IKK or drugs that inhibit NF-kB through other mechanisms, such as proteasome inhibitors, alone or in combination with . Note that Notch-1 or IKKa knockdown markedly inhibited NF-kB and CBF-1 luciferase activity by comparable extents in cells treated with either vehicle or cisplatin, indicating that cisplatin does not change the effects of Notch-1 or IKKa knockdown on the NF-kB and CBF-1 pathways and that the synergistic effects of these siRNAs with cisplatin are likely due to simultaneous inhibition of these pathways. DMSO, dimethylsulfoxide; IKK, I kappa B kinase; NF-kB, nuclear factor-kappa B; siRNA, small interfering RNA.
g-secretase inhibitors, may be effective in malignancies where the Notch and NF-kB pathways are pathogenetically important.
Materials and methods
Cell culture, reagents and plasmid constructs Human papilloma virus-positive human cervical cancer cell lines, CaSki, CSSC-7, HPV-16 and Siha from ATCC (Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. g-Secretase inhibitor I (GSI: cbz-Leu-Leu-Nle-CHO) was from Calbiochem (Darmstadt, Germany). Notch-1 N IC expression vector was from Dr Jon Aster (Harvard University). CBF-1-luciferase reporter plasmid was from Dr T Kadesch (University of Pennsylvania). All chemicals, unless specified otherwise, were purchased from Sigma/Aldrich Chemical Co. (St Louis, MO, USA).
RNA interference
Notch-1 and Notch-4 siRNA sequences (see Supplementary Information for details) were used as pSUPER constructs (OligoEngine, Seattle, WA, USA). Double-stranded siRNAs to IKKa and IKKb were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) (sc-29365, sc-35644) and transfected with OligoFectamine (Invitrogen, Carlsbad, CA, USA). For these experiments, control (Scrambled Stealth) dsRNA from Invitrogen was used. Notch-2 short hairpin RNA was obtained from Dr M Bocchetta (Loyola University, Chicago) and used as pLenti4/TO/V5-DEST construct, compared to scrambled control.
Cell-growth inhibition assay and measurement of apoptosis Cell growth inhibition assay was performed in a 96-well-plate format by crystal violet staining (Prochaska and Santamaria, 1988; Skehan et al., 1990) . Apoptosis was monitored by the ApoTarget Annexin-V FITC Apoptosis Kit (BioSource International Inc., Camarillo, CA, USA).
Transfection and dual-luciferase assays Dual-luciferase assays were performed using the Dual-Luciferase Assay system from Promega (Madison, WI, USA). In our experimental system, the expression of firefly luciferase driven by NF-kB promoter or by four consecutive CBF-1-responsive elements was used as an experimental reporter, whereas pRL-TK (Renilla luciferase) was cotransfected as an internal control. Student's t-test for paired samples was used to determine statistical significance of reporter data. Luciferase activity was expressed as the ratio firefly luciferase/Renilla luciferase/mg protein. Differences were considered statistically significant at Pp0.05.
NF-kB transcription factor DNA-binding assays
The levels of nuclear, DNA binding NF-kB subunits were assessed by utilizing the TransAM NF-kB Family Kit (Active Motif North America, Carlsbad, CA, USA) in a 96-well format according to the manufacturer's instructions. IP kinase assay IKK kinase assays were performed as described (Manna et al., 2000) . See Supplementary Information for details.
Western blot and coimmunoprecipitation

ChIP analysis
CaSki cells were transfected with Notch-1 siRNA or scrambled siRNA. Twenty-four hours post-transfection, cells were stimulated with TNF-a (10 ng/ml) for 30 min and fixed with 1% formaldehyde for 5 min. Chromatins from crosslinked cells were sheared by sonication and incubated overnight with specific primary antibodies, followed by incubation with protein G-Sepharose saturated with salmon sperm DNA. After immunoprecipitation, DNA was quantified using an Applied Biosystems ABI730 real-time PCR system. See Supplementary Information for primers and details.
Immunohistochemistry Anonymized, archival formalin-fixed, paraffin-embedded routine surgical specimens from the Department of Pathology, Mexican Institute for Social Security, as well as the University of Southern California, were stained as previously described (Nickoloff et al., 2002) using Vectastain Elite kits and counterstained with hematoxylin III.
